John Y. Caloz
2013
In 2013, John Y. Caloz earned a total compensation of $706.8K as Chief Financial Officer and Treasurer at CytRx.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $256,800 |
| Salary | $350,000 |
| Total | $706,800 |
Caloz received $350K in salary, accounting for 50% of the total pay in 2013.
Caloz also received $100K in bonus and $256.8K in option awards.
Rankings
In 2013, John Y. Caloz's compensation ranked 8,083rd out of 12,286 executives tracked by ExecPay. In other words, Caloz earned more than 34.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,083 out of 12,286 | 34th |
Division Manufacturing | 2,928 out of 4,612 | 37th |
Major group Chemicals And Allied Products | 910 out of 1,462 | 38th |
Industry group Drugs | 690 out of 1,156 | 40th |
Industry Biological Products, Except Diagnostic Substances | 110 out of 196 | 44th |
Source: SEC filing on May 20, 2016.
Caloz's colleagues
We found four more compensation records of executives who worked with John Y. Caloz at CytRx in 2013.
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019